Researchers at the Berlin Institute of Health at Charité (BIH) have used brain simulations to develop a theory on the formation of traveling waves of activity. These waves influence cognitive processes in the human brain such as learning or…
Berlin, 14 May 2024. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased sales by 17% to € 67.6 million in the first quarter of 2024 compared to the same period of the previous year. EBIT before special items from continuing operations…
As the leading event in Canada's and the USA’s medical technology sector, The Medtech Conference in Toronto offers a dynamic platform for startups, SMEs, accelerators, investors, and industry leaders to establish important connections, share…
Aignostics, a spin-off of Charité – Universitätsmedizin Berlin and alumnus of the Berlin Institute of Health Digital Health Accelerator Program, has been named to Newsweek’s inaugural ranking of the “World’s Best Digital Health Companies 2024.”
ProBioGen AG (Berlin/Germany), a premier Contract Development and Manufacturing Organization (CDMO) and technology provider with extensive expertise in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals, and…
Held once again at the Messe Berlin trade fair center, the DMEA, Europe’s most important event for digital health, provided an overview of the market and the opportunities for the future. The German capital region was again represented with a big…
roclub, a pioneer in teleoperation solutions for healthcare, has raised €4.0m in a seed financing round supported by European and American early-stage investors Speedinvest and FJ Labs alongside better ventures and strategic business angels.
New building for cutting-edge cardiovascular medicine in Berlin
Cultimate Foods, a biotech startup based in Berlin’s Biocube and Hannover (Institut für Technische Chemie, Leibniz Universität Hannover), successfully closes its seed round to scale up production processes, expand commercial collaborations and…
Insider information pursuant to Article 17 MAR
